Lyon, France
March 31, 2020

AMOEBA (FR0011051598 - AMEBA), producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces the signature of a Material Transfer Agreement (MTA) with BASF, one of the leaders in biocontrol in France 
 
The purpose of the research partnership is the provision by Amoéba of experimental products containing the amoeba lysate Willaertia magna C2c Maky. In return, the BASF group will carry out its own field and greenhouse trials to evaluate the performance of these products in preventing fungal diseases on a range of crops.   
 
Amoéba and BASF are thus embarking on a targeted research phase which, if successful, could promote the commercial development of biocontrol solutions. 
 
  "The use of our biocontrol solutions for trials on new types of crops, aims at diversifying and enriching alternative solutions in crop protection. This new partnership between Amoeba and BASF, which is present alongside farmers worldwide through its "Agricultural Solutions" division, illustrates the growing interest in the research work carried out by Amoeba over the past 10 years. These large-scale tests, with a world leader in the chemical industry, offer significant value-added potential for the company and are an essential step towards a possible commercial partnership". explains Fabrice Plasson, Chairman and CEO of Amoéba. 
 
Amoéba points out that the company is still in the testing phase for its biocide and biocontrol applications and does not currently market any products. 
 

Website: http://www.amoeba-biocide.com

Published: March 31, 2020